NCT00064064 2013-11-06
3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 2 Completed
Clinical Trials
3 trialsPhase 2 × Carcinoma, Non-Small-Cell Lung × 3-aminopyridine-2-carboxaldehyde thiosemicarbazone × Clear all
NCT00077415 2013-05-15
3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00077350 2013-02-27
A Phase II Trial of Triapine (NSC #663249) in Combination With Gemcitabine as Second Line Treatment of Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 2 Completed